Medias

Documents et medias

Vidéos

Toutes les vidéos

Brochures

iBiopsy®: Artificial Intelligence is our DNA

Toutes les brochures

White papers

Understanding Novel Response Patterns of Immunotherapies

Immunotherapies display novel response patterns that affect the design of imaging based studies and the subsequent evaluation of imaging data. Applying traditional chemotherapy-based response assumptions to immunotherapy trials can result in inaccurate interpretation of response, premature therapy termination, and unnecessary removal of subjects from a trial. Our unique solutions for medical image analysis and management and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy.

Tous les white papers

Case studies

Toutes les études de cas

Publications scientifiques

Discordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria

Y. Liu [1], A. Iannessi [1], L. Balcells [1], Y. WANG [2], J. Ching [2], C. Ojango [1] – Affiliations: [1] Median Technologies, 1800 Route des Crêtes, 06560 Valbonne, France. [2] Median Technologies, Shanghai, China.

Présenté à RSNA Annual Meeting, Nov. 27 – Dec. 1, 2022, Chicago, IL, USA.

Toutes les publications scientifiques